Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 RFI Ingredients, Optigenex Enter Agreement - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

RFI Ingredients, Optigenex Enter Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Optigenex, Inc., New York, NY, has signed an exclusive trademark licensing agreement for the territory of North America with RFI Ingredients, Blauvelt, NY, to market AC-11 in the health practitioner channel. The agreement will give RFI access to the AC-11 registered trademark and utilize the scientifically validated qualities of this unique compound. In third party pre-clinical and scientific studies, AC-11 has been shown to support the body’s natural ability to repair damage to DNA due to multiple causes, including harmful effects of UV radiation from exposure to the sun, stress, environmental pollution and other toxins. In addition, in separate third party studies AC-11 has been established as an inhibitor of pro-inflammatory agents and has demonstrated effectiveness as a natural immune stimulator and anti-tumor agent.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters